Related Experiment Video
Updated: Aug 13, 2026

Culture of Small Colony Variant of Pseudomonas aeruginosa and Quantitation of its Alginate
Published on: February 22, 2020
Mucopolysaccharidosis I: Alpha-L-Iduronidase mutations in three Tunisian families
1Mount Sinai School of Medicine, New York University, New York, NY 10029, USA.
Abstract:
Mucopolysaccharidosis type I (MPS I) is a lysosomal storage disease resulting from the defective activity of the enzyme alpha-L-iduronidase (IDUA). The disease has severe and milder phenotypic subtypes. The IDUA mutations in five MPS I patients from three unrelated families from central and southern Tunisia were determined by amplifying and sequencing each of the IDUA exons and intron-exon junctions. Two novel IDUA mutations, c.1805delTinsGAACA in exon 13 and I270S in exon 7, and two previously reported mutations, P533R and R628X, were detected. The two patients in family 1 who had the Hurler phenotype were homoallelic for the novel deletion-insertion mutation. The patient in family 2 who also had the Hurler phenotype was heteroallelic for the novel missense mutation I270S and the previously reported nonsense mutation R628X. The two patients in family 3 who had the Hurler-Scheie phenotype were homoallelic for P533R. In addition, six known IDUA polymorphisms were identified. These are the first Tunisian MPS I patients to be genotyped. The identification of these mutations and their genotype-phenotype correlations should facilitate prenatal diagnosis and counselling for MPS I in Tunisia, where a very high rate of consanguinity exists.
Insights
Researchers identified novel mutations in the alpha-L-iduronidase gene (IDUA) in Tunisian patients with Mucopolysaccharidosis type I (MPS I). This genetic discovery aids in understanding MPS I and facilitates prenatal diagnosis in Tunisia.
Area of Science:
- Genetics
- Biochemistry
- Rare Diseases
Background:
- Mucopolysaccharidosis type I (MPS I) is a genetic lysosomal storage disorder caused by deficient alpha-L-iduronidase (IDUA) enzyme activity.
- MPS I presents with a spectrum of clinical severity, ranging from severe to milder phenotypes.
Purpose of the Study:
- To identify and characterize IDUA gene mutations in five Tunisian patients with MPS I from three families.
- To establish genotype-phenotype correlations for MPS I in the Tunisian population.
Main Methods:
- DNA was extracted from patients, and IDUA exons and intron-exon junctions were amplified and sequenced.
- Mutation analysis involved identifying novel and known mutations in the IDUA gene.
Main Results:
- Two novel IDUA mutations (c.1805delTinsGAACA and I270S) and two previously reported mutations (P533R and R628X) were identified.
- Specific mutations were correlated with MPS I phenotypes (Hurler and Hurler-Scheie), with homoallelic and heteroallelic findings reported.
- Six known IDUA polymorphisms were also detected in the study cohort.
Conclusions:
- This study reports the first genetic characterization of MPS I patients in Tunisia.
- The identified mutations and their genotype-phenotype correlations are crucial for improving prenatal diagnosis and genetic counseling in Tunisia, especially given the high consanguinity rate.
More Related Videos
Related Concept Videos
Lysosomal Hydrolases
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteoglycans
Inborn Errors of Metabolism
ATP Synthase: Mechanism

